Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
Tsang Lau, Jawad AhmadDivision of Liver Diseases, Mount Sinai School of Medicine, New York, USAAbstract: The Model for End-Stage Liver Disease (MELD) score incorporates serum bilirubin, creatinine, and the international normalized ratio (INR) into a formula that provides a continuous variable that i...
Main Authors: | Lau T, Ahmad J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-02-01
|
Series: | Hepatic Medicine : Evidence and Research |
Online Access: | http://www.dovepress.com/clinical-applications-of-the-model-for-end-stage-liver-disease-meld-in-a12174 |
Similar Items
-
Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis
by: Patel Tushar, et al.
Published: (2002-01-01) -
The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil O impacto do MELD no transplante de fígado em um centro no Brasil
by: Alexandre Coutinho Teixeira de Freitas, et al.
Published: (2010-09-01) -
Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure
by: Shengen Liao, et al.
Published: (2021-03-01) -
Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
by: Guy N Brock, et al.
Published: (2019-01-01) -
Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
by: Ryo Konno, et al.
Published: (2019-01-01)